Bon Natural Life Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China

Reuters

2025/09/09

<a href="https://laohu8.com/S/BON">Bon Natural Life</a> Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China

Bon Natural Life Ltd. (NASDAQ: BON), a leader in the natural, health, and personal care industry, has announced an $18 million cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a key health products distributor in China. This 24-month, non-exclusive agreement will see Huahai Keyuan distribute BON's innovative second-generation Apple Series health products across Greater China. These products, which enhance weight management and metabolic health, leverage advanced low-temperature extraction technology to boost bioactivity by 80% compared to previous formulations. Industry analysts highlight the strong market potential, supported by consumers' growing interest in scientifically validated nutraceuticals. BON's CEO, Yongwei Hu, expressed confidence in the agreement's ability to drive significant revenue and profit growth in the nutraceutical and functional food markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bon Natural Life Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN68987) on September 09, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2566697824"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2566697824\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2566697824?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-09 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566697824","market":"us","top_or_hot":-1,"title":"Bon Natural Life Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/BON\">Bon Natural Life</a> Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bon Natural Life Ltd. (NASDAQ: BON), a leader in the natural, health, and personal care industry, has announced an $18 million cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a key health products distributor in China. This 24-month, non-exclusive agreement will see Huahai Keyuan distribute BON's innovative second-generation Apple Series health products across Greater China. These products, which enhance weight management and metabolic health, leverage advanced low-temperature extraction technology to boost bioactivity by 80% compared to previous formulations. Industry analysts highlight the strong market potential, supported by consumers' growing interest in scientifically validated nutraceuticals. BON's CEO, Yongwei Hu, expressed confidence in the agreement's ability to drive significant revenue and profit growth in the nutraceutical and functional food markets.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bon Natural Life Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN68987) on September 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bon Natural Life Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBon Natural Life Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-09 20:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/BON\">Bon Natural Life</a> Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Bon Natural Life Ltd. (NASDAQ: BON), a leader in the natural, health, and personal care industry, has announced an $18 million cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a key health products distributor in China. This 24-month, non-exclusive agreement will see Huahai Keyuan distribute BON's innovative second-generation Apple Series health products across Greater China. These products, which enhance weight management and metabolic health, leverage advanced low-temperature extraction technology to boost bioactivity by 80% compared to previous formulations. Industry analysts highlight the strong market potential, supported by consumers' growing interest in scientifically validated nutraceuticals. BON's CEO, Yongwei Hu, expressed confidence in the agreement's ability to drive significant revenue and profit growth in the nutraceutical and functional food markets.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bon Natural Life Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN68987) on September 09, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BON","symbol_name":"天美生物","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDL3qPFYb:1","article_id":"2566697824","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566697824","pubTimestamp":1757421041,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Bon Natural Life Ltd. , a leader in the natural, health, and personal care industry, has announced an $18 million cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a key health products distributor in China. This 24-month, non-exclusive agreement will see Huahai Keyuan distribute BON's innovative second-generation Apple Series health products across Greater China. These products, which enhance weight management and metabolic health, leverage advanced low-temperature extraction technology to boost bioactivity by 80% compared to previous formulations. Industry analysts highlight the strong market potential, supported by consumers' growing interest in scientifically validated nutraceuticals. BON's CEO, Yongwei Hu, expressed confidence in the agreement's ability to drive significant revenue and profit growth in the nutraceutical and functional food markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUB","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BON":"天美生物","BK4539":"次新股","BK4109":"特种化学制品"},"translate_title":"Bon Natural Life Ltd.与华海科源达成价值1800万美元的创新苹果系列保健品交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BON":0.9},"content_text":"Bon Natural Life Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China\n    \n\n        Bon Natural Life Ltd. (NASDAQ: BON), a leader in the natural, health, and personal care industry, has announced an $18 million cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a key health products distributor in China. This 24-month, non-exclusive agreement will see Huahai Keyuan distribute BON's innovative second-generation Apple Series health products across Greater China. These products, which enhance weight management and metabolic health, leverage advanced low-temperature extraction technology to boost bioactivity by 80% compared to previous formulations. Industry analysts highlight the strong market potential, supported by consumers' growing interest in scientifically validated nutraceuticals. BON's CEO, Yongwei Hu, expressed confidence in the agreement's ability to drive significant revenue and profit growth in the nutraceutical and functional food markets.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bon Natural Life Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN68987) on September 09, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}